ALS Centre, Department of Neuroscience, University of Torino, Via Cherasco 15, Torino 10126, Italy.
J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):377-81. doi: 10.1136/jnnp-2011-300472. Epub 2011 Oct 19.
To evaluate the clinical characteristics and outcome of non-invasive ventilation (NIV) in an epidemiological based series of amyotrophic lateral sclerosis (ALS) patients.
The study was performed using data from the Piemonte and Valle d'Aosta Register for ALS, a prospective epidemiological register enrolling all ALS incident cases in two Italian regions.
Among the 1260 patients incident in the period 1995-2004, 259 (20.6%) underwent NIV. Young male patients and subjects attending the tertiary ALS centres were more likely to undergo NIV. There was a progressive significant increase in the use of NIV during the study but was limited to patients attending the ALS tertiary centres. Median survival after NIV was 289 days (95% CI 255 to 333).
In an epidemiological setting, NIV represents an increasingly utilised option for the treatment of respiratory disturbances in ALS and has favourable effects on survival, in particular among patients followed by tertiary ALS centres. Sociocultural factors, such as age, gender and marital status, strongly influence the probability of undergoing NIV. Efforts should be made to remove these obstacles in order to spread the use of NIV in all ALS patients with respiratory failure.
评估基于人群的肌萎缩侧索硬化症(ALS)患者中使用无创通气(NIV)的临床特征和结局。
该研究使用来自皮埃蒙特和瓦莱达奥斯塔 ALS 登记处的数据进行,该前瞻性流行病学登记处纳入了两个意大利地区的所有 ALS 新发病例。
在 1995 年至 2004 年期间发病的 1260 例患者中,有 259 例(20.6%)接受了 NIV。年轻男性患者和到三级 ALS 中心就诊的患者更有可能接受 NIV。在研究期间,NIV 的使用呈逐渐显著增加趋势,但仅限于到 ALS 三级中心就诊的患者。接受 NIV 治疗后的中位生存时间为 289 天(95%CI 255 至 333)。
在人群环境中,NIV 作为治疗 ALS 呼吸障碍的一种越来越多的选择,对生存有积极影响,尤其是在接受三级 ALS 中心治疗的患者中。社会文化因素,如年龄、性别和婚姻状况,强烈影响接受 NIV 的概率。应努力消除这些障碍,以便在所有呼吸衰竭的 ALS 患者中推广使用 NIV。